SP availability and (mis) use in sub-Saharan Africa: Antimalarial market data from 8 countries

Download File


As evidence of reduced chloroquine efficacy against plasmodium falciparum mounted in the 1990’s, sulfadoxine-pyrimethamine (SP) became first-line malaria treatment in many endemic countries in sub-Saharan Africa (SSA). Between 2002-2005, countries in SSA adopted artemesinin combination therapies (ACT) as first-line treatment. SP is still recommended by the WHO and used across SSA for intermittent preventive treatment of malaria during pregnancy (IPTp).

We examine availability and distribution of SP using national antimalarial market survey trend data collected by the ACTwatch project.